Clinical

Dataset Information

0

Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors


ABSTRACT: This study is an open label prospective trial of TheraSphere treatment for patients who have liver metastases who have failed or are intolerant to other systemic or liver directed therapies. Patients will be treated with TheraSphere at doses of 120 ± 10% Gy, and then followed for time to progression (TTP), safety, and overall survival.

DISEASE(S): Adenocarcinoma,Neoplasm Metastasis,Carcinoma,Colorectal Neoplasms,Liver Neoplasms,Liver Diseases,Neoplasms

PROVIDER: 2093200 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2042885 | ecrin-mdr-crc
| 2101871 | ecrin-mdr-crc
| S-EPMC7529870 | biostudies-literature
2019-08-12 | GSE126481 | GEO
| 2019438 | ecrin-mdr-crc
2012-08-01 | E-GEOD-37791 | biostudies-arrayexpress
2012-08-01 | E-GEOD-37790 | biostudies-arrayexpress
2012-08-01 | E-GEOD-33474 | biostudies-arrayexpress
2012-08-02 | GSE33474 | GEO
2012-08-02 | GSE37790 | GEO